Eliem Therapeutics News

ELYMDelisted Stock  USD 3.04  0.04  1.30%   
About 61% of Eliem Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Eliem Therapeutics suggests that many traders are alarmed regarding Eliem Therapeutics' prospects. Eliem Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Eliem Therapeutics. Many technical investors use Eliem Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
over a week ago at news.google.com         
ELYM Stock Earnings Eliem Therapeutics Reported Results for Q4 2023 - MSN
Google News at Macroaxis
over a month ago at finance.yahoo.com         
Eliem Therapeutics Changes Name to Climb Bio
Yahoo News
over a month ago at news.google.com         
Eliem Therapeutics, Inc. Shares Sold by Driehaus Capital Management LLC - MarketBeat
Google News at Macroaxis
over a month ago at simplywall.st         
Selling Eliem Therapeutics Shares at a Lower Price Than Current Market Value May Have Been a Costly ...
Simply Wall St News at Macroaxis
over two months ago at finance.yahoo.com         
Private equity firms who have a significant stake must be disappointed along with institutions after...
Yahoo News
over two months ago at news.google.com         
Eliem Therapeutics to join the Russell 2000 and Russell 3000 indexes - MSN
Google News at Macroaxis
over two months ago at news.google.com         
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally Bridge Group NY LLC - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Eliem Therapeutics Recent Strategic Pipeline Restructuring - Seeking Alpha
Google News at Macroaxis
over two months ago at investing.com         
Eliem therapeutics executive sells over 9,000 in company stock
Investing News at Macroaxis
over two months ago at www.macroaxis.com         
Disposition of tradable shares by Emily Pimblett of Eliem Therapeutics at 8.06 subject to Rule 16b-3
Macroaxis News
over two months ago at thelincolnianonline.com         
Eliem Therapeutics, Inc. Sees Significant Increase in Short Interest
news
over two months ago at thelincolnianonline.com         
Acquisition by Emily Pimblett of 5000 shares of Eliem Therapeutics subject to Rule 16b-3
news
over two months ago at finance.yahoo.com         
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
Yahoo News
over three months ago at benzinga.com         
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems ...
benzinga news
over three months ago at news.google.com         
Eliem Therapeutics Executive Changes Amid Strategic Shift - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Eliem Therapeutics that are available to investors today. That information is available publicly through Eliem media outlets and privately through word of mouth or via Eliem internal channels. However, regardless of the origin, that massive amount of Eliem data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Eliem Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Eliem Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Eliem Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Eliem Therapeutics alpha.

Eliem Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
09/11/2024
2
Disposition of tradable shares by Emily Pimblett of Eliem Therapeutics at 8.06 subject to Rule 16b-3
09/20/2024
3
500,000 Shares in Eliem Therapeutics, Inc. Acquired by Ally Bridge Group NY LLC - MarketBeat
09/24/2024
4
ELYM Stock Earnings Eliem Therapeutics Reported Results for Q4 2023 - MSN
11/20/2024
Check out Eliem Therapeutics Hype Analysis, Eliem Therapeutics Correlation and Eliem Therapeutics Performance.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Eliem Stock

If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments